Fujii H[au] - Search Results

Year	Number of Results
1961	2
1962	6
1963	2
1964	6
1965	5
1966	3
1967	5
1968	2
1969	6
1970	7
1971	5
1972	6
1973	5
1974	15
1975	17
1976	5
1977	19
1978	20
1979	26
1980	26
1981	20
1982	30
1983	43
1984	29
1985	73
1986	45
1987	62
1988	61
1989	64
1990	51
1991	42
1992	46
1993	57
1994	57
1995	65
1996	60
1997	42
1998	74
1999	67
2000	79
2001	108
2002	107
2003	80
2004	110
2005	91
2006	104
2007	113
2008	119
2009	120
2010	116
2011	136
2012	137
2013	150
2014	139
2015	139
2016	133
2017	123
2018	115
2019	138
2020	155
2021	171
2022	173
2023	43

1

Surgical techniques and postoperative management to prevent postoperative pancreatic fistula after pancreatic surgery.

Kawaida H, Kono H, Hosomura N, Amemiya H, Itakura J, Fujii H, Ichikawa D. Kawaida H, et al. Among authors: fujii h. World J Gastroenterol. 2019 Jul 28;25(28):3722-3737. doi: 10.3748/wjg.v25.i28.3722. World J Gastroenterol. 2019. PMID: 31391768 Free PMC article. Review.

2

The Role of Insulin Resistance and Diabetes in Nonalcoholic Fatty Liver Disease.

Fujii H, Kawada N, Japan Study Group Of Nafld Jsg-Nafld. Fujii H, et al. Int J Mol Sci. 2020 May 29;21(11):3863. doi: 10.3390/ijms21113863. Int J Mol Sci. 2020. PMID: 32485838 Free PMC article. Review.

3

Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999-2019: a systematic review and meta-analysis.

Li J, Zou B, Yeo YH, Feng Y, Xie X, Lee DH, Fujii H, Wu Y, Kam LY, Ji F, Li X, Chien N, Wei M, Ogawa E, Zhao C, Wu X, Stave CD, Henry L, Barnett S, Takahashi H, Furusyo N, Eguchi Y, Hsu YC, Lee TY, Ren W, Qin C, Jun DW, Toyoda H, Wong VW, Cheung R, Zhu Q, Nguyen MH. Li J, et al. Among authors: fujii h. Lancet Gastroenterol Hepatol. 2019 May;4(5):389-398. doi: 10.1016/S2468-1253(19)30039-1. Epub 2019 Mar 20. Lancet Gastroenterol Hepatol. 2019. PMID: 30902670

4

Antidiabetic Therapy in the Treatment of Nonalcoholic Steatohepatitis.

Sumida Y, Yoneda M, Tokushige K, Kawanaka M, Fujii H, Yoneda M, Imajo K, Takahashi H, Eguchi Y, Ono M, Nozaki Y, Hyogo H, Koseki M, Yoshida Y, Kawaguchi T, Kamada Y, Okanoue T, Nakajima A, Jsg-Nafld JSGON. Sumida Y, et al. Among authors: fujii h. Int J Mol Sci. 2020 Mar 11;21(6):1907. doi: 10.3390/ijms21061907. Int J Mol Sci. 2020. PMID: 32168769 Free PMC article. Review.

5

Klippel-Trenaunay Syndrome.

Suda T, Katagiri A, Fujii H. Suda T, et al. Among authors: fujii h. Intern Med. 2022 Sep 28. doi: 10.2169/internalmedicine.0251-22. Online ahead of print. Intern Med. 2022. PMID: 36171122 Free article. No abstract available.

6

Hepatocyte-specific fibroblast growth factor 21 overexpression ameliorates high-fat diet-induced obesity and liver steatosis in mice.

Yano K, Yamaguchi K, Seko Y, Okishio S, Ishiba H, Tochiki N, Takahashi A, Kataoka S, Okuda K, Liu Y, Fujii H, Umemura A, Moriguchi M, Okanoue T, Itoh Y. Yano K, et al. Among authors: fujii h. Lab Invest. 2022 Mar;102(3):281-289. doi: 10.1038/s41374-021-00680-9. Epub 2021 Nov 3. Lab Invest. 2022. PMID: 34732847 Free article.

7

The Effects of AHCC®, a Standardized Extract of Cultured Lentinura edodes Mycelia, on Natural Killer and T Cells in Health and Disease: Reviews on Human and Animal Studies.

Shin MS, Park HJ, Maeda T, Nishioka H, Fujii H, Kang I. Shin MS, et al. Among authors: fujii h. J Immunol Res. 2019 Dec 20;2019:3758576. doi: 10.1155/2019/3758576. eCollection 2019. J Immunol Res. 2019. PMID: 31930148 Free PMC article. Review.

8

IL-19 Contributes to the Development of Nonalcoholic Steatohepatitis by Altering Lipid Metabolism.

Azuma YT, Fujita T, Izawa T, Hirota K, Nishiyama K, Ikegami A, Aoyama T, Ike M, Ushikai Y, Kuwamura M, Fujii H, Tsuneyama K. Azuma YT, et al. Among authors: fujii h. Cells. 2021 Dec 13;10(12):3513. doi: 10.3390/cells10123513. Cells. 2021. PMID: 34944021 Free PMC article.

9

Oligoribonucleotide interference-PCR: principles and applications.

Shimizu T, Fujita T, Fujii H. Shimizu T, et al. Among authors: fujii h. Biol Methods Protoc. 2022 May 13;7(1):bpac010. doi: 10.1093/biomethods/bpac010. eCollection 2022. Biol Methods Protoc. 2022. PMID: 35664805 Free PMC article. Review.

10

Clinical characteristics and treatment of 50 cases of Blau syndrome in Japan confirmed by genetic analysis of the NOD2 mutation.

Matsuda T, Kambe N, Ueki Y, Kanazawa N, Izawa K, Honda Y, Kawakami A, Takei S, Tonomura K, Inoue M, Kobayashi H, Okafuji I, Sakurai Y, Kato N, Maruyama Y, Inoue Y, Otsubo Y, Makino T, Okada S, Kobayashi I, Yashiro M, Ito S, Fujii H, Kondo Y, Okamoto N, Ito S, Iwata N, Kaneko U, Doi M, Hosokawa J, Ohara O, Saito MK, Nishikomori R; PIDJ members in the JSIAD; PIDJ (Primary Immunodeficiency and Autoinflammatory Diseases Database Project) members in the JSIAD (Japanese Society for Immunodeficiency and Autoinflammatory Diseases). Matsuda T, et al. Among authors: fujii h. Ann Rheum Dis. 2020 Nov;79(11):1492-1499. doi: 10.1136/annrheumdis-2020-217320. Epub 2020 Jul 9. Ann Rheum Dis. 2020. PMID: 32647028

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results